LAUSR

1. Felix-Ilemhenbhio F, Pickering GAE, Kiss-Toth E, Wilkinson JM. Pathophysiology and emerging molecular therapeutic targets in heterotopic ossification. Int J Mol Sci. 2022;23:6983. doi:10.3390/ ijms23136983 2. Bastepe M. GNAS mutations and heterotopic ossification. Bone. 2018;109:80-85. doi:10.1016/j.bone.2017.09.002 3. Mantovani G, Bastepe M, Monk D, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol. 2018;14:476-500. doi:10. 1038/s41574-018-0042-0 4. Weinstein LS, Gejman PV, Friedman E, et al. Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 1990;87:8287-8290. doi:10.1073/pnas.87.21.8287 5. Shore EM, Kaplan FS. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6:518-527. doi:10.1038/ nrrheum.2010.122 6. Elli FM, DeSanctis L, Ceoloni B, et al. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations. Hum Mutat. 2013;34:411-416. doi:10. 1002/humu.22265 7. Andrés-Ramos I, Alegría-Landa V, Gimeno I, et al. Cutaneous elastic tissue anomalies. Am J Dermatopathol. 2019;41:85-117. doi:10.1097/ DAD.0000000000001275 8. Wang AR, Kent K, Jagdeo J, Robinson-Bostom L, Bercovitch L. Nevus anelasticus: how should such lesions be classified? J Cutan Pathol. 2014;41:519-523. doi:10.1111/cup.12311 9. Ishii N, Baba N, Kanaizuka I, Nakajima H, Ono S, Amemiya F. Histopathological study of focal dermal hypoplasia (Goltz syndrome). Clin Exp Dermatol. 1992;17:24-26. doi:10.1111/j.1365-2230.1992. tb02527.x 10. Rohdenburg C, Liersch J, Kutsche K, Schaller J. Fragmented elastic fibers in focal dermal hypoplasia (Goltz-Gorlin syndrome) without focal dermal hypoplasia: report of a male case and review of the literature. Am J Dermatopathol. 2020;42:653-661. doi:10.1097/DAD. 0000000000001579 11. Goujon E, Beer F, Gay S, Sandre D, Gouyon JB, Vabres P. Anetoderma of prematurity: an iatrogenic consequence of neonatal intensive care. Arch Dermatol. 2010;146:565-567. doi:10.1001/archdermatol.2010.65 12. García-Martínez FJ, Duat-Rodriguez A, Torrelo A, Noguera-Morel L, Hernández-Martín A. Hypopigmented macules in neurofibromatosis type 1: a case control study. J Am Acad Dermatol. 2021;84:11281130. doi:10.1016/j.jaad.2020.06.071 13. Saikaly SK, Schoch JJ, Motaparthi K, Shenoy A, Knapik JA, Bender NR. Generalized infantile myofibromatosis with visceral involvement presenting as diffuse hypopigmented macules at birth. Pediatr Dermatol. 2021;38:249-252. doi:10.1111/pde.14456 14. Matthews BG, Wee NKY, Widjaja VN, Price JS, Kalajzic I, Windahl SH. αSMA osteoprogenitor cells contribute to the increase in osteoblast numbers in response to mechanical loading. Calcif Tissue Int. 2020;106:208-217. doi:10.1007/s00223-019-00624-y 15. Lietman SA, Ding C, Cooke DW, Levine MA. Reduction in Gs alpha induces osteogenic differentiation in human mesenchymal stem cells. Clin Orthop Relat Res. 2005;434:231-238. doi:10.1097/01.blo. 0000153279.90512.38 16. Lebrun M, Richard N, Abeguile G, et al. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab. 2010;95:3028-3038. doi:10. 1210/jc.2009-1451